loader image

LATVIAN

BIOMEDICAL

RESEARCH AND STUDY CENTRE


RESEARCH AND EDUCATION IN BIOMEDICINE FROM GENES TO HUMAN

Project Title: „The development of an efficient pilot-scale leghemoglobine production technology, based on recombinant Pichia pastoris and Kluyveromyceslactis fed-batch fermentations (BioHeme)”

Funding: European Regional Development Fund (ERDF), Measure 1.1.1.1 “Support for applied research”

Project No.: 1.1.1.1/21/A/044

Period: 1 January 2022 – 30 November 2023

Project costs: 540 540,00 EUR

Project implementer: Latvian State Institute of Wood Chemistry

Cooperation partner: Latvian Biomedical Research and Study Centre

Principle Investigator BMC: Dr.biol. A. Kazāks

Project summary:

An alternative to livestock production can be plant-based meat. Plant-based meat is defined as a meat-like substance made from vegetarian friendly ingredients. Plant-based meat reproduces the flavour and texture of real meat without using products of animal origin. In plant-based meats, the leghemoglobin protein (LegH) is essential to comprise the unique flavour and aroma of traditional meat. As of now, the most perspective process of manufacturing LegH in appropriate amounts, is through fermentation using recombinant microorganism strains defined as methylotrophic yeast (for example, Pichiapastoris), which utilize methanol as substrate, and in their recombinant form can produce LegH via methanol-inducible promoter element. The mentioned research is driven by two problems, which are: (1) the use of volatile and flammable substances during the production process and (2) relatively high cost of applicable substrates. One of biological platforms, which was not studied earlier for the production of LegH and can potentially outperform P.pastoris is Kluyveromyces lactis. The mentioned organism can grow on cheap substrates, such as cheese whey, and does not require the use of methanol for protein synthesis induction. Therefore, the objective of the BioHeme project: is to develop effective fed-batch fermentation and scale-up techniques for the production of plant-based meat substitutes, utilizing a recombinant LegH producing strain of Pichia pastoris and Kluyveromyceslactis. The main activities of the BioHeme project are: (i) obtainment of recombinant (LegH producing) strains of P. Pastoris and K. lactis, with a subsequent evaluation of heme production efficiency and technological potential, (ii) optimization of fermentation medium composition for biomass growth and hemeprotein production phases for the two mentioned recombinant strains, (iii) the application of Model-Predictive control systems for the control of biomass growth rates and hemeprotein synthesis, (iv) fermentation process transfer to pilot scale and evaluation of applications sustainability.

Information published 03.01.2022.

Progress of the project:

1 January 2022 – 31 March 2022

We have designed genes and constructed appropriate vectors for expression of soy leghemoglobin (LegHb) intracellularly and secretory in yeast P. pastoris and K. lactis systems. In case of K. lactis no detectable LegHb synthesis has been demonstrated in both expression variants. In contrast, for P. pastoris well-detectable high level protein synthesis was observed intracellularly.  However, attempts to improve expression by lowering temperature, addition of iron ions and increasing cultivation temperature did not give expected results. In addition, for P. pastoris secretion of LegHb was also detected, but expression medium dis not have characteristic reddish brown color. It has been decided that secreted protein does not contain heme group and therefore is not useful for set goals. We consider selection of other alternative yeast hosts as S. cerevisiae in nearest future.

Information published 31.03.2022.

Progress of the project:

1 April 2022 – 30 June 2022

We have developed fast and efficient purification method for soy leghemoglobin (LegHb) from Pichia pastoris cells. It was detected that in current conditions ~1 mg LegHb can be obtained from 1 g wet cells. This amount could be estimated as medium high.

We continued attempts to obtain LegHb synthesis in yeast Kluyveromyces lactis. It was believed that in these cells production can not be detected, but performing purification by developed method a small amount of target protein was recognized. Outcome, however, is significantly lower than in P. pastoris.

As alternative to K. lactis, novel genes were designed and vectors constructed for intracellular expression of LegHb in yeasts Saccharomyces cerevisiae and Hansenula polymorpha. Currently no LegHb synthesis has been confirmed in both cases. A further optimization of expression conditions is in progress.

Information published 30.06.2022.